We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Surgical Sealing Biomaterial Could Eliminate Standard Methods of Suturing and Stapling

By HospiMedica International staff writers
Posted on 31 Mar 2023
Print article
Image: New robust thermosensitive bioadhesives can improve surgical sealing (Photo courtesy of Pexels)
Image: New robust thermosensitive bioadhesives can improve surgical sealing (Photo courtesy of Pexels)

For surgical wounds to be properly closed, the sealant material used must effectively seal on wet, slippery tissue surfaces that vary in shape and may involve tissue movement, such as an expanding lung, or have crumbly textures. The application and effectiveness of the sealant must also occur within a suitable timeframe for surgical procedures. Traditional methods such as suturing and stapling can be ineffective and time-consuming, leading to increased blood loss. Fibrin-based bioadhesive sealants are expensive, exhibit insufficient adhesion, and are susceptible to viral transmission. Although commercial gelatin-based wound dressings offer biocompatibility, low cost, and hemostatic effectiveness, they lack adhesive strength due to inherent brittleness. Previous efforts to improve adhesion through functionalization with catechol, a naturally occurring compound that can provide adhesive capabilities when bound to gelatin, have been made. However, the limited number of binding sites on the gelatin results in a low level of adhesion achievable through catechol functionalization.

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI, Los Angeles, CA, USA) have utilized innovative chemistry to create an injectable biomaterial that has considerably enhanced adhesive strength, stretchability, and toughness. This hydrogel, based on gelatin and modified chemically, has numerous appealing features, including fast gelation at room temperature and customizable levels of adhesion. This specially designed biomaterial is ideal as a surgical wound sealant due to its injectability and controllable adhesion, as well as its superior ability to stick to a range of tissue and organ surfaces.

The researchers utilized caffeic acid (CA), a naturally occurring compound found in coffee and olive oil, to enhance the tissue adhesion properties of gelatin. To achieve this, they first oxidized CA to create CA oligomers (CAO), which consist of a small number of repeating catechol units. By coupling these CA derivatives with gelatin, they were able to significantly improve the chemical binding of catechol groups and enhance their adhesive capabilities. As a result, the engineered bioadhesive sealant exhibits superior adhesive strength, stretchability, toughness, and injectability, and can rapidly gel at the wound site, while maintaining stable adhesion under physiological conditions.

In addition, the sealants were engineered to exhibit selective tissue adhesion. This is crucial for effective sealing, as there must be strong bonding between the sealant and tissue at the interface, while avoiding adhesion on the opposite face of the sealant that is exposed to bodily fluids. Validation tests conducted on wet collagen sheets, as well as burst pressure experiments to assess the limits of adhesive strength, confirmed the efficacy of the new sealant and contradicted previous reports suggesting adverse effects of oxidative chemistry.

The newly developed sealant was put to the test on pig lung, heart, and bladder wounds in laboratory experiments. Results showed that the sealant's adhesive strength was significantly greater than that of commercial gelatin-based sealants. Even after being scraped and twisted experimentally, the sealant remained firmly affixed to the tissue surface. The biocompatibility of the sealant was also confirmed through testing. The sealant exhibited drug loading and drug release capabilities and demonstrated potential for promoting antioxidant effects that can aid in wound healing. This versatile technique can be applied to other biomaterials to impart strong adhesion.

“Our team has utilized manipulative and strategic chemistry to significantly improve adhesive strength and versatility in biomaterials,” said Ali Khademhosseini, TIBI’s Director and CEO. “This creates exciting possibilities for more effective surgical wound management in the clinic.”

Related Links:

Gold Supplier
Portable X-Ray System
FDR Xair
Hydraulic Surgeon's Chair/Stool
Chair Scale
seca 954
CFM Device
EEGDigiTrack CFM/aEEG Devices

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.